Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 5/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.43 |
| ▸ | SRD5A2 | P31213 | 6/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.41 |
| ▸ | AR | P10275 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7609968 | 1.00 | SRD5A1 (0.63) | SRD5A1CYP2C19CYP19A1SRD5A2CYP17A1 | |
| SCHEMBL7611466 | 0.85 | SRD5A1 (0.63) | SRD5A1CYP2C19CYP19A1SRD5A2CYP17A1 | |
| SCHEMBL7619286 | 0.85 | SRD5A1 (0.61) | SRD5A1CYP2C19CYP19A1CYP17A1AR | |
| SCHEMBL7619280 | 0.85 | SRD5A1 (0.61) | SRD5A1CYP2C19CYP19A1CYP17A1AR | |
| SCHEMBL7611459 | 0.85 | SRD5A1 (0.63) | SRD5A1CYP2C19CYP19A1SRD5A2CYP17A1 | |
| SCHEMBL8065397 | 0.83 | SRD5A1 (0.60) | SRD5A1CYP2C19CYP19A1SRD5A2CYP17A1 | |
| SCHEMBL8065395 | 0.83 | SRD5A1 (0.60) | SRD5A1CYP2C19CYP19A1SRD5A2CYP17A1 | |
| SCHEMBL7613573 | 0.82 | SRD5A1 (0.67) | SRD5A1CYP19A1ARESR1ESR2 | |
| SCHEMBL7613570 | 0.82 | SRD5A1 (0.67) | SRD5A1CYP19A1ARESR1ESR2 | |
| SCHEMBL8075542 | 0.81 | SRD5A1 (0.57) | SRD5A1CYP2C19CYP19A1SRD5A2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0880540-B1 | 17-BETA-CYCLOPROPYL(AMINO/OXY) 4-AZA STEROIDS AS ACTIVE INHIBITORS OF TESTOSTERONE 5-ALPHA-REDUCTASE AND C17-20-LYASE | AVENTIS PHARMA INC (US) | 2002-06-12 | — | — | EP | disclosed |
| US-6365597-B1 | FOR THERAPY OF ANDROGEN AND ESTROGEN MEDIATED DISORDERS, INCLUDING BENIGN PROSTATIC HYPERPLASIA, ANDROGEN MEDIATED PROSTATE CANCER, ESTROGEN MEDIATED BREAST CANCER AND ACNE | AVENTIS PHARMACEUTICALS INC. | 2002-04-02 | — | — | US | disclosed |
| EP-0880540-A1 | 17-BETA-CYCLOPROPYL(AMINO/OXY) 4-AZA STEROIDS AS ACTIVE INHIBITORS OF TESTOSTERONE 5-ALPHA-REDUCTASE AND C17-20-LYASE | HOECHST MARION ROUSSEL, INC. (US) | 1998-12-02 | — | — | EP | disclosed |
| WO-1997030069-A1 | 17-BETA-CYCLOPROPYL(AMINO/OXY) 4-AZA STEROIDS AS ACTIVE INHIBITORS OF TESTOSTERONE 5-ALPHA-REDUCTASE AND C17-20-LYASE | HOECHST MARION ROUSSEL, INC. (US) | 1997-08-21 | — | — | WO | disclosed |